Helix BioMedix, Inc. aksje
HXBM
Forsinket 0 min$1.79000.0000 (0.00%)
Laster graf...
Helix BioMedix, Inc.
Market Cap
$402,227
Åpning1.7900
Høy1.7900
Lav1.7900
Volum100
P/EN/A
Markedsverdi402.23k
52-ukers høy7.1800
52-ukers lav1.0000
Gj.sn. volum41
UtbytteN/A
Beta1.34
EPS-0.9000
Om Helix BioMedix, Inc. aksje
Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company was founded in 1988 and is based in Bothell, Washington.
Selskapsinformasjon
Børs: OTC Markets OTCPK (PNK)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
19125 Northcreek Parkway
98011 Bothell, United States
98011 Bothell, United States
Telefon: + 425 402 8400
Nettside: https://www.helixbiomedix.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål